GreenLight Biosciences and Samsung Biologics have announced a partnership agreement in which Samsung Biologics will manufacture GreenLight’s messenger RNA COVID-19 vaccine candidate at commercial scale. The partnership aims to accelerate...

View the Online Magazine

Launches

New website launches Tower Cold Chain’s global brand identity

Pharmaceutical thermal protection specialist Tower Cold Chain has launched a new brand identity, supported by a new website that provides an enhanced experience for...

Entia rases £12m to launch virtual oncology solution

Med tech business, Entia, has raised $12 million in a funding round to launch a virtual oncology solution. Entia Library will allow patients to perform...

Theramex launches first and only body-identical combined hormone therapy treatment for post-menopausal women

Theramex has launched Bijuva® / Bijuve® (1mg oestradiol / 100mg progesterone) across Europe and the UK. Bijuva® - known as Bijuve® in the UK –...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Envirotainer launches CryoSure® – a revolution in -70ºC cryogenic shipping

Envirotainer, the global market leader in secure cold chain solutions for intercontinental shipments of pharmaceuticals, is launching the CryoSure® platform today. This -70oC solution,...

Timestrip introduces new vaccine temperature indicator

Timestrip®, the developer of smart indicator technology, has introduced a new temperature indicator that helps healthcare professionals avoid wastage of vaccines.  Travelling with packs...

Humanigen signs contract with Clinigen for Lenzilumab Managed Access Program in Europe

Humanigen, a Californian clinical-stage biopharma company focused on preventing and treating an immune hyper-response called ‘cytokine storm’, has entered into an arrangement with Clinigen...

GSK to supply Canada with 10,000 doses of COVID vaccine

GSK has signed an agreement with the Government of Canada to supply 10,000 doses of Sotrovimab for injection, a COVID-19 monoclonal antibody therapy developed...

Approvals

FDA approves first treatment for common type of post-transplant infection that is resistant to other drugs

The U.S. Food and Drug Administration has approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients (12 years of age...

NICE approves first long-acting injectable HIV-1 treatment

NICE has published draft guidance recommending the first long-acting injectable treatment for HIV-1 infection in adults. The draft guidance is the first time NICE has...

Manufacturiung

Finance

Research & Development
Latest

Nykode Therapeutics to collaborate with Regeneron to develop vaccines against cancer and infectious diseases

Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, has entered into a license and collaboration agreement...

£1.2m project to improve global availability of microneedle drug delivery technology

Microneedles are considered more effective at delivering certain drugs than traditional intravenous injections or oral methods, but they are not widely used. Lack of commercialisation...

New approach provides potential vaccine and treatment for Alzheimer’s

A promising new approach to potentially treat Alzheimer’s disease – and also vaccinate against it – has been developed by a team of UK...

Kala Pharmaceuticals snaps up developer of regenerative biotherapies

Kala Pharmaceuticals, a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, has acquired Combangio,...

Pioneering Far-UVC technology that kills 99.98% of pathogens including COVID to be trialled

A forward-looking Yorkshire-based business that was launched in spring 2020 in response to the COVID-19 pandemic has been awarded a £271,000 grant by Innovate...

Appointments